Crypto market cap $2.14 T −4.25%24h volume $85.6 BBTC dominance 58.0%Fear & Greed 12/100BTC $62,043.90 −2.56%ETH $1,756.69 −2.65%S&P 500 (SPY) $715.87 −1.96%Gold $3,580.40 −2.85%Updated 2026-11-20
★ 💼

Neurocrine Biosciences market cap

Market capRevenueEarnings

As of November 2026, Neurocrine Biosciences (NBIX) has a market capitalization of $15.85 B, which makes it #844 among the world’s largest public companies. Over the past year its value changed by +2.91%.

Market cap$15.85 B
World rank#844
1 year+2.91%
Share price$156.59

Market cap over time

By year

YearValueChange
2026$15.85 B+10.4%
2025$14.36 B+3.90%
2024$13.82 B+3.60%
2023$13.34 B+10.3%
2022$12.09 B+40.2%
2021$8.62 B−11.1%
2020$9.70 B−10.8%
2019$10.88 B+50.5%
2018$7.23 B−7.96%
2017$7.85 B+100%
2016$3.92 B−31.6%
2015$5.73 B+153%

Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-20. Not investment advice.

Follow us
TelegramX (Twitter)BlueskyMediumPinterest✉ support@whatifstack.com🤝 partners@whatifstack.com
Popular
BitcoinEthereumSolanaXRPNvidiaAppleTeslaGoldS&P 500 ETFNasdaq-100 ETF
Markets
MarketsCompareCryptocurrencyStockETFMetalCommodityUnited KingdomCanadaAustraliaUnited StatesUkraine
Tools
CompareConverterLargest companiesFamous investorsLargest assetsMemecoinsBitcoin halvingCalculators
Insights
GuideNewsInsightsRSSActivitiesExchangesAbout & methodologyEditorial policyFor partners & advertisers